Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg

PURPOSE: To evaluate the intraocular pressure (IOP) reducing effect of a fixed combination of 0.005% latanoprost and 0.5% timolol in patients with an IOP of 30 mmHg or higher. DESIGN: Prospective, randomized clinical trial. PARTICIPANTS: Twenty-eight patients. METHODS: Patients had received no prior...

Descripción completa

Detalles Bibliográficos
Autores principales: Özkurt, Yelda Buyru, Sengor, Tomris, Evciman, Tufan, Haboğlu, Melih, Baş, Gökçen, Aydın, Sevda
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708984/
https://www.ncbi.nlm.nih.gov/pubmed/19668587
_version_ 1782169253891276800
author Özkurt, Yelda Buyru
Sengor, Tomris
Evciman, Tufan
Haboğlu, Melih
Baş, Gökçen
Aydın, Sevda
author_facet Özkurt, Yelda Buyru
Sengor, Tomris
Evciman, Tufan
Haboğlu, Melih
Baş, Gökçen
Aydın, Sevda
author_sort Özkurt, Yelda Buyru
collection PubMed
description PURPOSE: To evaluate the intraocular pressure (IOP) reducing effect of a fixed combination of 0.005% latanoprost and 0.5% timolol in patients with an IOP of 30 mmHg or higher. DESIGN: Prospective, randomized clinical trial. PARTICIPANTS: Twenty-eight patients. METHODS: Patients had received no prior medical glaucoma treatment. Routine ophthalmic examinations and visual field tests were performed before and after treatment for each patient. RESULTS: Mean IOP was 32.28 ± 0.92 mmHg before treatment. Mean IOP levels were 18.75 ± 0.68 for the first day, 17.96 ± 0.90 for the first week and 17.64 ± 0.66 for the first month after treatment. CONCLUSION: A fixed combination of latanoprost 0.005% and timolol 0.5% is effective in significantly reducing IOP in glaucoma patients with an IOP greater than 30 mmHg.
format Text
id pubmed-2708984
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-27089842009-08-10 Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg Özkurt, Yelda Buyru Sengor, Tomris Evciman, Tufan Haboğlu, Melih Baş, Gökçen Aydın, Sevda Clin Ophthalmol Original Research PURPOSE: To evaluate the intraocular pressure (IOP) reducing effect of a fixed combination of 0.005% latanoprost and 0.5% timolol in patients with an IOP of 30 mmHg or higher. DESIGN: Prospective, randomized clinical trial. PARTICIPANTS: Twenty-eight patients. METHODS: Patients had received no prior medical glaucoma treatment. Routine ophthalmic examinations and visual field tests were performed before and after treatment for each patient. RESULTS: Mean IOP was 32.28 ± 0.92 mmHg before treatment. Mean IOP levels were 18.75 ± 0.68 for the first day, 17.96 ± 0.90 for the first week and 17.64 ± 0.66 for the first month after treatment. CONCLUSION: A fixed combination of latanoprost 0.005% and timolol 0.5% is effective in significantly reducing IOP in glaucoma patients with an IOP greater than 30 mmHg. Dove Medical Press 2009 2009-06-02 /pmc/articles/PMC2708984/ /pubmed/19668587 Text en © 2009 Özkurt et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Özkurt, Yelda Buyru
Sengor, Tomris
Evciman, Tufan
Haboğlu, Melih
Baş, Gökçen
Aydın, Sevda
Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
title Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
title_full Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
title_fullStr Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
title_full_unstemmed Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
title_short Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
title_sort administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmhg
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708984/
https://www.ncbi.nlm.nih.gov/pubmed/19668587
work_keys_str_mv AT ozkurtyeldabuyru administrationofthefixedcombinationoflatanoprost0005andtimolol05inglaucomapatientswithanintraocularpressureover30mmhg
AT sengortomris administrationofthefixedcombinationoflatanoprost0005andtimolol05inglaucomapatientswithanintraocularpressureover30mmhg
AT evcimantufan administrationofthefixedcombinationoflatanoprost0005andtimolol05inglaucomapatientswithanintraocularpressureover30mmhg
AT haboglumelih administrationofthefixedcombinationoflatanoprost0005andtimolol05inglaucomapatientswithanintraocularpressureover30mmhg
AT basgokcen administrationofthefixedcombinationoflatanoprost0005andtimolol05inglaucomapatientswithanintraocularpressureover30mmhg
AT aydınsevda administrationofthefixedcombinationoflatanoprost0005andtimolol05inglaucomapatientswithanintraocularpressureover30mmhg

Ejemplares similares